Dr Agarwals - Public Comps and Valuation Multiples

Dr Agarwals Overview

About Dr Agarwals

Dr Agarwal’s Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.

Founded

2010

HQ

Employees

3.4K+

Website

dragarwals.co.in

Sectors

Hospitals & Clinics

Financials

LTM Revenue $216M

LTM EBITDA $57.7M

EV

$1.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Dr Agarwals Financials

As of November 2025, Dr Agarwals reported last 12-month revenue of $216M and EBITDA of $57.7M.

In the same period, Dr Agarwals generated $173M in LTM gross profit and $12.7M in net income.

See Dr Agarwals valuation multiples based on analyst estimates

Dr Agarwals P&L

In the most recent fiscal year, Dr Agarwals reported revenue of $190M and EBITDA of $55.4M.

Dr Agarwals expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Dr Agarwals valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$216M	XXX	$190M	XXX	XXX	XXX
Gross Profit	$173M	XXX	$85.5M	XXX	XXX	XXX
Gross Margin	80%	XXX	45%	XXX	XXX	XXX
EBITDA	$57.7M	XXX	$55.4M	XXX	XXX	XXX
EBITDA Margin	27%	XXX	29%	XXX	XXX	XXX
EBIT	$28.7M	XXX	$27.6M	XXX	XXX	XXX
EBIT Margin	13%	XXX	15%	XXX	XXX	XXX
Net Profit	$12.7M	XXX	$9.3M	XXX	XXX	XXX
Net Margin	6%	XXX	5%	XXX	XXX	XXX
Net Debt	XXX	XXX	$15.9M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Dr Agarwals including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $216M. EBITDA for the last twelve months was $57.7M. In the most recent fiscal year, Dr Agarwals achieved $190M in revenue and $55.4M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$216M	Analyst estimates available to subscribers	$190M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$173M	Analyst estimates available to subscribers	$85.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	80.0% gross margin	Analyst estimates available to subscribers	45.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$57.7M	Analyst estimates available to subscribers	$55.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	26.7% EBITDA margin	Analyst estimates available to subscribers	29.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$28.7M	Analyst estimates available to subscribers	$27.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	13.2% EBIT margin	Analyst estimates available to subscribers	14.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$12.7M	Analyst estimates available to subscribers	$9.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	5.9% net profit margin	Analyst estimates available to subscribers	4.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$15.9M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Dr Agarwals

This financial data table provides comprehensive performance metrics for Dr Agarwals, a company based in India. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Dr Agarwals generated $216M in revenue over the last twelve months.
The company achieved $57.7M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $173M.
Net income over the last twelve months reached $12.7M.

Fiscal Year Performance

In the most recent fiscal year, Dr Agarwals reported $190M in total revenue.
Fiscal year EBITDA was $55.4M.
The company maintained a gross profit margin of 45.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 29.2%.
Net profit margin reached 4.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Dr Agarwals. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Dr Agarwals Stock Performance

Dr Agarwals has current market cap of INR 161B (or $1.8B), and EV of INR 166B (or $1.9B).

Market Cap Evolution

Dr Agarwals Stock Data

As of December 4, 2025, Dr Agarwals's stock price is INR 508 (or $6).

See Dr Agarwals trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.9B	$1.8B	XXX	XXX	XXX	XXX	$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Dr Agarwals Valuation Multiples

Dr Agarwals's trades at 10.3x EV/Revenue multiple, and 35.0x EV/EBITDA.

See valuation multiples for Dr Agarwals and 15K+ public comps

Dr Agarwals Financial Valuation Multiples

As of December 4, 2025, Dr Agarwals has market cap of $1.8B and EV of $1.9B.

Equity research analysts estimate Dr Agarwals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Dr Agarwals has a P/E ratio of 140.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.8B	XXX	$1.8B	XXX	XXX	XXX
EV (current)	$1.9B	XXX	$1.9B	XXX	XXX	XXX
EV/Revenue	8.6x	XXX	10.3x	XXX	XXX	XXX
EV/EBITDA	32.1x	XXX	35.0x	XXX	XXX	XXX
EV/EBIT	64.6x	XXX	70.3x	XXX	XXX	XXX
EV/Gross Profit	10.7x	XXX	n/a	XXX	XXX	XXX
P/E	140.6x	XXX	192.8x	XXX	XXX	XXX
EV/FCF	-69.9x	XXX	287.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Dr Agarwals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Dr Agarwals Margins & Growth Rates

Dr Agarwals's last 12 month revenue growth is 19%

Dr Agarwals's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $17K for the same period.

Dr Agarwals's rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dr Agarwals's rule of X is 75% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Dr Agarwals and other 15K+ public comps

Dr Agarwals Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	19%	XXX	21%	XXX	XXX	XXX
EBITDA Margin	27%	XXX	30%	XXX	XXX	XXX
EBITDA Growth	20%	XXX	15%	XXX	XXX	XXX
Rule of 40	49%	XXX	49%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	75%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$17K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	4%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	31%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial